Cost-effectiveness of cataract surgery in Japan

被引:30
作者
Hiratsuka Y. [1 ]
机构
[1] Care of Hiratsuka Y, Natl Inst Publ Hlth, Dept Management Sci, Wako, Saitama 3510197, Japan
关键词
Cataract surgery; Cost-effectiveness; Cost-utility; QALYs; Time tradeoff; QUALITY-OF-LIFE; TIME TRADE-OFF; VISUAL IMPAIRMENT; HEALTH STATES; UTILITY; POPULATION; CARE;
D O I
10.1007/s10384-011-0041-3
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
To evaluate the cost-effectiveness of cataract surgery through measurement of the cost per quality-adjusted life-year (QALY) in Japan. A total of 549 patients scheduled for cataract surgery at 12 clinical sites from November 2008 through February 2010 were included in the study. Prospective assessment of patient preference-based quality of life (utility) was performed before and after the surgery using the time tradeoff method, EuroQol, and Health Utilities Index Mark 3. Multiple regression analysis was used to determine the correlation between utility and visual acuity. The QALYs gained through cataract surgery were estimated, and cost-utility analysis was performed. The utilities significantly correlated with the visual acuity in the better seeing eye. In all the subgroups (first eye surgery, second eye surgery, and bilateral surgery), mean utility improvement was statistically significant. Average QALYs for unilateral cataract surgery and bilateral cataract surgery were 2.40 and 3.40, respectively. The cost per QALY gained from surgery was estimated at Ayen122,472 (US $1,307) for unilateral surgery and Ayen145,562 (US $1,553) for bilateral surgery. Routine cataract surgery in Japan is highly cost-effective. Factors that contribute to this are the high clinical effectiveness of the surgery, the substantial improvement in patient-perceived quality of life, and the reasonable cost of the surgery.
引用
收藏
页码:333 / 342
页数:10
相关论文
共 39 条
[1]  
[Anonymous], SURV MED CAR ACT PUB
[2]  
[Anonymous], Abridged life tables in Japan for 1962-2014
[3]   Valuing health states for use in cost-effectiveness analysis [J].
Brazier, John .
PHARMACOECONOMICS, 2008, 26 (09) :769-779
[4]  
Brown G C, 1999, Trans Am Ophthalmol Soc, V97, P473
[5]  
Brown G C, 2001, Trans Am Ophthalmol Soc, V99, P199
[6]  
Brown M.M., 2005, EVIDENCE BASED VALUE
[7]   Cost-utility analysis of cataract surgery in the second eye [J].
Busbee, BG ;
Brown, MM ;
Brown, GC ;
Sharma, S .
OPHTHALMOLOGY, 2003, 110 (12) :2310-2317
[8]   Incremental cost-effectiveness of initial cataract surgery [J].
Busbee, BG ;
Brown, MM ;
Brown, GC ;
Sharma, S .
OPHTHALMOLOGY, 2002, 109 (03) :606-612
[9]   Using Effectiveness and Cost-effectiveness to Make Drug Coverage Decisions A Comparison of Britain, Australia, and Canada [J].
Clement, Fiona M. ;
Harris, Anthony ;
Li, Jing Jing ;
Yong, Karen ;
Lee, Karen M. ;
Manns, Braden J. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (13) :1437-1443
[10]   Valuing Condition-Specific Health States Using Simulation Contact Lenses [J].
Czoski-Murray, Carolyn ;
Carlton, Jill ;
Brazier, John ;
Young, Tracey ;
Papo, Natalie L. ;
Kang, Hyong Kwon .
VALUE IN HEALTH, 2009, 12 (05) :793-799